Overview

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus
Phase:
Phase 2
Details
Lead Sponsor:
Saniona
Collaborator:
Profil Institut für Stoffwechselforschung GmbH
Treatments:
Metoprolol